Whole blood, serum, plasma single drug assay kit, 15 ng/L

In recent years, the demand for accurate and sensitive drug detection in biological samples has surged across multiple scientific research fields, including pharmacology, toxicology, clinical pharmacokinetics, and forensic toxicology. Researchers and laboratory professionals often face challenges in quantifying low-concentration drug components in complex biological matrices—such as whole blood, serum, and plasma—where interfering substances (e.g., proteins, lipids, endogenous metabolites) can obscure target signals, leading to inaccurate or unreliable results. Traditional detection methods, such as basic immunoassays or early-generation chromatographic techniques, often fail to meet the rigorous requirements of modern research: many lack the sensitivity to detect drugs at concentrations below 20 ng/mL, require cumbersome sample pretreatment steps (e.g., multiple extraction or purification cycles), or are limited to a single type of biological sample, restricting experimental flexibility.

Against this backdrop, the development of specialized assay kits tailored for multi-sample-type drug detection has become a critical focus. Our Whole Blood, Serum, Plasma Single Drug Assay Kit (Cat.No: CD-00142) addresses these industry pain points by leveraging advanced bioanalytical technologies. Unlike conventional kits that may only support serum or plasma testing, this product is optimized to handle three common biological sample types—whole blood, serum, and plasma—eliminating the need for researchers to purchase separate kits for different samples and reducing experimental costs and workflow complexity.

Key drivers behind the kit’s development include:
Growing demand for low-level drug quantification: In pharmacokinetic studies, tracking drug concentrations in vivo often requires detecting trace amounts (10–50 ng/mL) of drugs to analyze absorption, distribution, metabolism, and excretion (ADME) profiles. This kit’s 15 ng/mL cut-off and detection limit directly meet this need, ensuring no missed data points for low-concentration drug samples.
Need for simplified workflows: Traditional drug assay protocols may involve 2–3 hours of sample preparation (e.g., protein precipitation, solid-phase extraction) before detection. Our kit streamlines this process with pre-optimized reagents and step-by-step instructions, minimizing hands-on time and reducing the risk of human error.
Versatility for cross-field research: Whether used in academic laboratories studying drug-drug interactions, pharmaceutical R&D teams evaluating new drug candidates, or forensic research investigating drug-related cases, the kit’s compatibility with multiple sample types makes it a flexible tool for diverse research objectives.
Regulatory and reproducibility requirements: Modern scientific research emphasizes data reproducibility and compliance with standard operating procedures (SOPs). This kit undergoes rigorous quality control (QC) testing—including batch-to-batch consistency checks, sensitivity validation, and specificity verification—to ensure stable performance across different experiments and laboratories.